Moreover, several studies have reported that transferrin and soluble transferrin receptor (sTfR) are associated with obesity, metabolic syndrome and other cardiovascular risk factors in adults and children [10–12]. Here, TF is linked to obesity due to melanocortin 4 receptor deficiency.